Utah Medical Products Inc (NASDAQ:UTMD) has 116 institutional investors that have filed 13F reports for the period ending September 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BRANDES INVESTMENT PARTNERS, LP | 31 Mar, 2026 | 449,279 | 97,957 | 27.88% | $27,850,805.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 197,908 | 1,399 | 0.71% | $12,269,266.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 187,649 | 3,112 | 1.69% | $11,632,375.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 184,114 | -9,500 | -4.91% | $11,413,227.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 138,560 | 138,560 | 0.00% | $8,589,334.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 120,097 | 32,302 | 36.79% | $7,446,218.00 |
| Minerva Advisors LLC | 31 Mar, 2026 | 93,615 | 0 | 0.00% | $5,803,194.00 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 89,131 | -19,870 | -18.23% | $5,525,231.00 |
| RICE HALL JAMES & ASSOCIATES, LLC | 31 Mar, 2026 | 67,882 | 3,484 | 5.41% | $4,208,005.00 |
| State Street Corp | 31 Mar, 2026 | 64,402 | -3,605 | -5.30% | $4,012,910.00 |
| Morgan Stanley | 31 Mar, 2026 | 48,801 | 5,096 | 11.66% | $3,025,271.00 |
| UBS Group AG | 31 Mar, 2026 | 36,916 | 36,602 | 11,656.69% | $2,288,423.00 |
| Huber Capital Management LLC | 31 Mar, 2026 | 35,915 | -925 | -2.51% | $2,226,371.00 |
| Bank of New York Mellon Corp | 31 Mar, 2026 | 32,082 | -3,457 | -9.73% | $1,988,733.00 |
| Northern Trust Corp | 31 Mar, 2026 | 30,292 | 1,015 | 3.47% | $1,877,801.00 |
| Quantinno Capital Management LP | 31 Mar, 2026 | 29,841 | 6,146 | 25.94% | $1,849,870.00 |
| Cardinal Capital Management | 31 Mar, 2026 | 26,543 | 1,707 | 6.87% | $1,653,629.00 |
| EVERETT HARRIS & CO /CA/ | 31 Mar, 2026 | 25,564 | 4,220 | 19.77% | $1,584,712.00 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 31 Mar, 2026 | 21,287 | 6,384 | 42.84% | $1,319,581.00 |
| LSV ASSET MANAGEMENT | 31 Mar, 2026 | 19,859 | 6,385 | 47.39% | $1,231.00 |